# A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

> **NCT02731131** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 12 (actual)

## Conditions studied

- Hepatitis D, Chronic

## Interventions

- **DRUG:** Peginterferon alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT02731131
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02731131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02731131, "A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02731131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*